Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doris Mangelberger

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Immunology|August 21, 2023
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphomaMaria Patra-Kneuer, Gaomei Chang, Wendan Xu, et al.
Neoplasia (New York, N.Y.)|February 24, 2019
Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell CarcinomaJae Eun Choi, Monique E Verhaegen, Sahr Yazdani, et al.
EMBO Molecular Medicine|February 2, 2012
Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cellsMarkus Eberl, Stefan Klingler, Doris Mangelberger, et al.
International Journal of Cancer|July 11, 2018
Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinomaChristina Sternberg, Wolfgang Gruber, Markus Eberl, et al.
Haematologica|June 27, 2024
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamabAlexander Biedermann, Maria Patra-Kneuer, Dimitrios Mougiakakos, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Frontiers in Immunology|August 21, 2023
Activity of tafasitamab in combination with rituximab in subtypes of aggressive lymphomaMaria Patra-Kneuer, Gaomei Chang, Wendan Xu, et al.
Neoplasia (New York, N.Y.)|February 24, 2019
Characterizing the Therapeutic Potential of a Potent BET Degrader in Merkel Cell CarcinomaJae Eun Choi, Monique E Verhaegen, Sahr Yazdani, et al.
EMBO Molecular Medicine|February 2, 2012
Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cellsMarkus Eberl, Stefan Klingler, Doris Mangelberger, et al.
International Journal of Cancer|July 11, 2018
Synergistic cross-talk of hedgehog and interleukin-6 signaling drives growth of basal cell carcinomaChristina Sternberg, Wolfgang Gruber, Markus Eberl, et al.
Haematologica|June 27, 2024
Blockade of the CD47/SIRPα checkpoint axis potentiates the macrophage-mediated antitumor efficacy of tafasitamabAlexander Biedermann, Maria Patra-Kneuer, Dimitrios Mougiakakos, et al.
Pageof 2